Cisplatin infusion rate

Author: mtvp

August undefined, 2024

WebTo assess nephrotoxicity, both the incidence of acute kidney injury (AKI) grade 1 and the maximum decrease in estimated glomerular filtration rate (eGFR) were determined. … WebBlood samples were collected at 0.5, 1, 1.5, 2, 3 and 5 hours from the start of the infusion in the 1hour infusion group and at 2, 3, 3.5, 4, 6 and 24 hours from the start of the …

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB ...

WebSep 21, 2016 · Cisplatin is the most ototoxic drug known, and a mean ototoxicity incidence of 33% has been reported when patients received a single dose of 50 mg/m 2 of cisplatin. 1 Investigations using audiometric techniques revealed a frequency of cisplatin-induced ototoxicity of approximately 20% to 40% after a high cumulative dose of cisplatin of 400 … WebDec 21, 2024 · The maximum decrease in eGFR was 14.8 mL/min in the rapid infusion cohort and 17.7 mL/min in the regular infusion cohort (P = 0.364). What is new and … cisplatin oncolink

Cisplatin (Platinol®) OncoLink

WebApr 15, 2024 · He was then started on pirarubicin bladder infusion, along with 3 cycles of gemcitabine and cisplatin for his metastatic, high-grade non-muscle invasive bladder … WebMay 1, 2024 · Assessments occurred at early (first or second cycle) and late (last or second to last cycle) cisplatin infusions. Results: The most common diagnoses were central nervous system tumors (58 [36%]), neuroblastoma (43 [27%]), … cisplatin nw

The effect of rapid infusion of cisplatin on nephrotoxicity …

Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin …

WebMay 1, 2024 · Carboplatin Injection is supplied as a sterile, pyrogen-free, aqueous solution available in 50 mg/5 mL, 150 mg/15 mL, 450 mg/45 mL or 600 mg/60 mL multiple-dose vials containing 10 mg/mL of Carboplatin for administration by intravenous infusion. Each mL contains 10 mg Carboplatin and Water for Injection, USP. WebCisplatin is approved to be used alone or with other drugs to treat: Bladder cancer. It is used alone in patients with advanced cancer that cannot be treated with other therapies, such as surgery or radiation therapy. Ovarian cancer that has spread to other parts of the body. It is used with other drugs in patients who have already had surgery ... cisplatin oralWebFeb 16, 2024 · Cisplatin dosing information Usual Adult Dose for Testicular Cancer: 20 mg/m2 by slow IV infusion daily for 5 days per cycle in combination with other approved … cisplatin ops

"Weband biological effects. The differences in potencies for carboplatin and cisplatin appear to be directly related to the difference in aquation rates. In patients with creatinine clearances of about 60 mL/min or greater, plasma levels of intact carboplatin decay in a biphasic manner after a 30-minute intravenous infusion of " - Cisplatin infusion rate

Cisplatin infusion rate

Cisplatin (Intravenous Route) Side Effects - Mayo Clinic

WebFeb 20, 2024 · The frequencies of Grade 3-4 neutropenia, anemia, and thrombocytopenia varied from 48% to 71%, 8% to 28%, and 5% to 55%, respectively, in patients receiving Gemzar in combination with another drug [see Adverse Reactions ( 6.1 )]. Prior to each dose of Gemzar, obtain a complete blood count (CBC) with a differential and a platelet … WebSep 6, 2024 · [Amount of drug] [Infusion volume] [Infusion rate] [Prescribed dose] [ 100 ml ] [10-15 minutes] ... See cisplatin package insert for more information. 2.2 Single-Agent Use Nonsquamous Non-Small Cell Lung Cancer The recommended dose of ALIMTA is 500 mg/m2 administered as an intravenous infusion over 10 minutes on Day 1 of each 21 …

Did you know?

Webinfusion concentrate contains: 1 mg/mL cisplatin, 9 mg/mL sodium chloride, hydrochloric acid and/or sodium hydroxide to adjust pH, and water for injection to a final volume of 50 … WebFeb 1, 2024 · drowsiness. feeling of fullness in the ears. fever or chills. increased thirst. loss of appetite. loss of balance. loss of hearing. lower back or side pain. nausea or vomiting.

WebFeb 11, 2024 · Reported rates of CIHL following cisplatin exposure vary widely from 1·7% to 90·1%. Risk factors for developing CIHL are not well characterised and, apart from cumulative cisplatin dose, very few risk … WebFeb 17, 2024 · IV: Cisplatin has been infused over 30 minutes to 4 hours, at a rate of 1 mg/minute, or as a continuous infusion (off-label rates); infusion rate varies by protocol (refer to specific protocol for infusion …

WebCisplatin Injection infusion concentrate is a clear, colorless, sterile aqueous solution available in amber vials. Each 50 mL or 100 mL amber vial of infusion concentrate … WebNational Center for Biotechnology Information

WebA systematic review was performed to evaluate clinical studies that have examined hydration and supplementation strategies to prevent cisplatin-induced nephrotoxicity. Materials and methods: The University of Oxford Centre for Evidence-Based Medicine criteria were used to grade level of evidence. Results:

WebSep 18, 2024 · National Center for Biotechnology Information diamond\\u0027s a0WebSep 21, 2016 · For a number of years, cisplatin has been considered the most active drug for the treatment of cervical cancer, with initial response rates as high as 50%. 2 More recent trials with larger numbers of patients have reported response rates in … diamond\\u0027s 9wWebApr 15, 2024 · He was then started on pirarubicin bladder infusion, along with 3 cycles of gemcitabine and cisplatin for his metastatic, high-grade non-muscle invasive bladder urothelial carcinoma, from October 2024 to December 2024. ... headache, and palpitations and on electrocardiography, atrial fibrillation with a rapid ventricular rate was reported ... diamond\u0027s 9yWebEffect of Cisplatin Arterial Infusion (CAI) on Primary Nonmetastatic Pelvic Osteosarcoma: A Preliminary Study . Fulltext; Metrics; Get Permission; Cite this article; Authors Hu X , Chen X, Li T , Liu Z, Guo X, Ouyang Z . Received 29 November 2024. Accepted for publication 28 … cisplatin orally administeredWebCisplatin is administered through a vein (intravenously or IV) as an infusion. There is no pill form of cisplatin. Cisplatin is an irritant. An irritant is a chemical that can cause … diamond\\u0027s 9tWebFeb 16, 2024 · Usual Adult Dose for Ovarian Cancer. 75 to 100 mg/m2 by slow IV infusion once every 3 to 4 weeks on Day 1. Comments: The dosing presented is manufacturer … diamond\u0027s 9xWebIn patients receiving high-dose cisplatin plus metoclopramide, increasing the administration time from one hour to eight hours resulted in a small but significant decrease in emesis … diamond\\u0027s a4